Buy Epclusa (Sofosbuvir/Velpatasvir) licensed generic 'MyHep All'. It's produced by Mylan Pharmaceuticals Ltd®, a US FDA certified manufacturer, in India. It's a direct-acting antiviral used to treat chronic Hepatitis C (HCV) across all genotypes.

Buy Generic Epclusa (sofosbuvir/velpatasvir) – FDA Certified Manufacturer

Name: Buy Generic Epclusa (sofosbuvir/velpatasvir) – FDA Certified...
SKU: 10440
Price: 248.00 USD
Availability: InStock

$248.00 USD

MyHep All™ is a licensed generic of Epclusa®. It’s a direct-acting antiviral (DAA) used to treat Chronic Hepatitis C (HCV) across all genotypes in patients with or without liver cirrhosis. For most patients, 12 weeks of treatment is needed to reach cure. MyHep All™ is produced by a US FDA certified manufacturer in India.

Bottle Size : 28 Tablets (4 weeks supply)

Active Ingredients : Sofosbuvir 400 mg / Velpatasvir 100 mg

Produced by Mylan Pharmaceuticals®

No prescription? You can order our prescription service at checkout (cost is $10 USD).

To get a prescription for this medication from our doctor, 2 blood tests that can be done without a doctor’s order are required: CBC, CMP

Delivery of this medication is fully guaranteed and takes 4 to 6 days by Express Mail

In stock

Add to Wishlist

SKU: 10440 Category: Hepatitis C Tags: HCV, Mylan Pharmaceuticals®

Epclusa® overall established cure rate across all 6 strains of Hepatitis C is roughly 96%
For treatment experienced genotype 3 patients or for patients with advanced Liver cirrhosis (decompensated), treatment duration is 24 weeks instead of 12 weeks
Epclusa®’s side effects profile is quite mild especially with enough water intake
Consult a doctor before concurrent administration of other drugs and supplements to avoid drug interactions
Epclusa® is approved by the FDA and EMA for use in adults and children aged six years and older or weighing at least 37 pounds (17 kilograms)
You can visit the FixHepC forum for more information about Hepatitis C treatment